GetTopicDetailResponse(id=75501269e508, topicName=d2受體親和力, introduction=, content=抗精神病藥物 d2受體親和力, image=null, comments=0, allHits=217, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat May 17 17:12:15 CST 2025, time=2025-05-17, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=504570, tagList=[TagDto(tagId=504570, tagName=d2受體親和力)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2265457, encodeId=f8f9226545e8b, content=<a href='/topic/show?id=6c6b5559ea5' target=_blank style='color:#2F92EE;'>#抗精神病藥物#</a> <a href='/topic/show?id=75501269e508' target=_blank style='color:#2F92EE;'>#d2受體親和力#</a>, objectTitle=World Psychiatry：首次精神病發(fā)作后抗精神病藥物減停期間的復發(fā)風險, objectType=article, longId=877836, objectId=62018e7836c6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240621/1718954222455_92910.jpg, objectUrl=/article/show_article.do?id=62018e7836c6, replyNumber=0, likeNumber=23, createdTime=2025-05-17, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=62018e7836c6, moduleTitle=World Psychiatry：首次精神病發(fā)作后抗精神病藥物減停期間的復發(fā)風險, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=62018e7836c6)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-05-17發(fā)表于上海
